Ondine Biopharma Corporation
Ondine Biopharma Inc. (Ondine) is a preclinical stage pharmaceutical company engaged in the development and commercialization of novel therapies for oral infectious disease.
Ondine is currently involved in the development of a proprietary technology for treating infections using light-activated drugs.
Ondine is currently in preclinical development of the PACT technology and anticipates entering human clinical trials in both the UK and the United States during 2001. Based on the current development plans, a PACT product for treating periodontal disease could be on the market within the next four to five years.
During the commercial development and regulatory approval of PACT for periodontal disease, Ondine intends to expand its product portfolio to include other medical applications of PACT, as well as acquiring new platform technologies for the treatment of infectious disease.
Company Details
Year Established:
1998
Number of Employees:
5
Company Information
Carolyn Cross
Title:
Chief Executive Officer
Telephone:
(604) 669-0555
Fax:
(604) 669-0533
Email:
Click Here
Nicolas Loebel
Title:
Chief Technical Officer
Telephone:
(425) 882-0264
Email:
Click Here
Dj Feinstadt
Title:
Business Analyst
Telephone:
(604) 669-0555
Fax:
(604) 669-0533
Email:
Click Here
Products
Pharmaceuticals
Services